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Background and objectives: Evidence-based public health uses a population-centered 
approach to provide the basis for activities in the field of public health. However, research 
in public health tends to cover complex and context-dependent issues. This is particularly 
true for studies dealing with environmental risk factors. The synopsis aims at synthesizing 
the (methodological) challenges that are linked to environmental epidemiology and 
evidence-based public health, using the example of SHS exposure.  
 
Methods and materials: The synopsis is based on six publications, which rely on different 
methodological concepts. The publications focus on several aspects related to SHS 
exposure, be it 1) the impact of SHS exposure on health, or 2) the effects of legislation to 
reduce SHS exposure, 3) factors associated with SHS exposure in different countries, 
including results from different settings or different types of SHS exposure, or 4) a 
summary of challenges in creating evidence in environmental health risk assessments.  
 
Results: Environmental epidemiology has much to contribute to facilitate population 
health. Although there may be several shortcomings in environmental epidemiological 
studies dealing with SHS exposure, this type of observational research is necessary. 
Standardized approaches in public health are needed, particularly for the assessment of 
exposure and outcome in (environmental) epidemiological studies. Nevertheless, a focus 
on only one gold standard is not justified. Since public health acts on several levels, an 
interdisciplinary approach that uses the most appropriate methods from the respective 
disciplines of research traditions to create evidence is necessary. All decisions in public 
health should be evidence-based, irrespective of the area of interest. 
 
Conclusion: The need for evidence-based public health is obvious in all stages of the 
public health action cycle (assessment, policy formulation, implementation, and 
evaluation). Therefore, public health researchers must succeed in using the most 
appropriate methods. Perhaps an approach termed “evidence-based environmental 
epidemiology” will be formulated in the future. However, all types of research conducted 
in public health must use sound methods. That, besides the inclusion of patient values and 




Improving the evidence is an important goal for research and practice in public health. The 
availability of evidence-based information about risk factors and their associations with 
adverse health outcomes helps to ensure that policies designed to improve populations’ 
health may lead to their desired effects (Fielding and Briss, 2006). Evidence-based public 
health, therefore, uses a population-centered approach to provide the basis for activities in 
the field of public health (Brownson et al., 2009b; Gerhardus et al., 2010). However, 
research in public health tends to cover complex and context-dependent issues (Rychetnik 
et al., 2002). This is particularly true for studies dealing with environmental risk factors, 
where the exposure is involuntary, often infrequent, and sometimes even not observable.  
One example of such a risk factor is second-hand smoke (SHS) exposure. Evidence of the 
adverse health effects attributable to SHS exposure is available, and concern about these 
effects has contributed to the declining social acceptance of smoking, which resulted in 
legislation bringing in smoking bans and action to reduce SHS exposure (Öberg et al., 
2011; Paoletti et al., 2012; Prokhorov et al., 2013). Nevertheless, SHS still remains the 
most important contaminant of indoor air (Law and Hackshaw, 1996; Öberg et al., 2011). 
To develop and establish suitable strategies for the protection of non-smokers—but also 
smokers—from the harms of SHS exposure, evidence on the magnitude of the association 
between SHS exposure and adverse health outcomes is needed just as much as evidence on 
the impact of tobacco-control strategies. This evidence is to be generated in the field of 
public health, supported by adjacent scientific disciplines. 
The present synopsis aims at synthesizing the (methodological) challenges that are linked 
to environmental epidemiology and evidence-based public health, using the example of 
SHS exposure. The cumulative dissertation consists of the following six publications1, 
which are shortly described within this synopsis: 
 
[1] Fischer, F., Kraemer, A. (2015). Meta-analysis of the association between second-
hand smoke exposure and ischaemic heart diseases, COPD and stroke. BMC Public 
Health, 15, 1202. 
[2] Fischer, F., Kraemer, A. (2016). Health Impact Assessment for Second-Hand 
Smoke Exposure in Germany – Quantifying Estimates for Ischaemic Heart 
Diseases, COPD, and Stroke. International Journal of Environmental Research and 
Public Health, 13 (2), 198.  
                                                 
1 The numeration of the publications will be used throughout the synopsis.  
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[3] Fischer, F., Kraemer, A. (2016). Factors associated with secondhand smoke 
exposure in different settings: Results from the German Health Update (GEDA) 
2012. BMC Public Health, 16 (1), 327. 
[4] Fischer, F., Kraemer, A. (submitted). Secondhand Smoke Exposure at Home 
among Middle and High School Students in the United States – Does the Type of 
Tobacco Product Matter?. BMC Public Health.  
[5] Fischer, F., Minnwegen, M., Kaneider, U., Kraemer, A., Khan, M. M. H. (2015). 
Prevalence and Determinants of Secondhand Smoke Exposure Among Women in 
Bangladesh, 2011. Nicotine and Tobacco Research, 17 (1), 58-65.  
[6] Fischer, F. (2016). Challenges in creating evidence in environmental health risk 
assessments: The example of second-hand smoke. Challenges, 7 (1), 2.  
 
The main focus will not be on the specific results of these publications, but on the 
overarching aspects that are of concern for evidence-based public health derived from 
environmental epidemiological studies.  
 
 
2. Evidence-based decision-making in public health based on research in 
environmental epidemiology 
At the most basic level, evidence involves the available body of information based on 
studies to indicate whether a belief, proposition, or association is true or valid (Jewell and 
Abate, 2001). The concept of evidence-based practice is well-established in several 
disciplines, such as psychology (Presidential Task Force on Evidence-Based Practice, 
2006), social work (Gambrill, 2003), and nursing (Melnyk et al., 2000). It can be assumed 
that it is best established in medicine (Brownson et al., 2009b). Almost 25 years have 
passed since a group of researchers coined the term “evidence-based medicine” to provide 
a more scientific and systematic approach to the practice of medicine (Evidence-Based 
Medicine Working Group, 1992). The origins of this concept can be traced back to the 
work of Archibald Cochrane. He noted that many medical treatments lacked scientific 
effectiveness (Cochrane, 1972). The group around Gordon Guyatt and David Sackett, as 
the main promoters of evidence-based medicine, aimed to integrate the best available 
external clinical/research evidence with clinical expertise and patient values (Sackett et al., 
1996; Sackett et al., 2000).  
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According to their idea of evidence-based medicine, it can be defined as “the process of 
systematically finding, appraising, and using contemporaneous research findings as the 
basis for clinical decisions” (Rosenberg and Donald, 1995) or “the conscientious, explicit, 
and judicious use of current best evidence in making decisions about the care of individual 
patients” (Sackett et al., 1996). The stages of evidence-based medicine are described as 
1) the assessment and synthesis of external evidence (by using appropriate methods and 
study designs) and 2) the use of probabilistic reasoning that takes a clinical attitude, as well 
as the patients’ values and preferences, into account (Gray, 1997; Sackett et al., 1996). 
Over time, discussions in the scientific community led to the impression that only evidence 
from explanatory randomized controlled trials (RCTs) can be classified as reliable. This 
narrowed definition of external evidence focusing on RCTs as a “gold standard” came up 
with the development of clinical guidelines (Fernandez et al., 2015; Moten et al., 2016). 
Nevertheless, the role of the RCTs as a gold standard is controversial for several reasons. 
The most important criticism of this aspect, among others, deals with the fact that evidence 
based on RCTs may sometimes be unattainable for methodological or ethical reasons. This 
is particularly true for evidence that is or has to be generated in the “real world”, apart 
from clinical trials. Furthermore, critics hold that the so-called hierarchy of evidence 
downgrades other sorts of (clinical) evidence and leaves no way of integrating results from 
other study designs into an overall assessment of the evidence (Ashcroft, 2004). 
Nevertheless, the rise of evidence-based medicine is an important movement and 
represents a meaningful epistemological turn in medicine (Ashcroft, 2004; Davidovitch 
and Filc, 2006).  
 
2.1 Evidence-based public health 
In recent years, a more evidence-based approach to public health has emerged, based on 
the advances of evidence-based medicine. Gray (1997) published one of the first articles 
mentioning the concept of evidence-based public health in 1997. This approach followed 
the emergence of evidence-based medicine to facilitate health policies and interventions 
based on results from scientifically sound studies (Davidovitch and Filc, 2006; Kohatsu et 
al., 2004). There are several connections between evidence-based medicine, evidence-
based public health, and epidemiology. The concept of evidence-based medicine evolved 
from clinical epidemiology (Heller and Page, 2002; Jenicek, 1997). Therefore, the 
fundamental role of epidemiology in all kinds of evidence-based decisions in medicine or 
public health has to be highlighted (Jenicek, 1997). In addition, the focus of evidence-
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based medicine is also the population and not just the individual patient, as it is in clinical 
practice (Heller and Page, 2002). Jenicek (1997) published a review describing the links 
between epidemiology, evidence-based medicine, and evidence-based public health. 
Within this review, epidemiology was claimed as the foundation for both evidence-based 
medicine and evidence-based public health (Jenicek, 1997).   
Evidence-based public health is needed to develop, implement, and evaluate interventions 
and policies of scientific reasoning to promote the health of (sub-)populations (Brownson 
et al., 2003; Brownson et al., 1999). Because of the similarities between the concepts of 
evidence-based medicine and evidence-based public health, the latter can be described as 
“the conscientious, explicit, and judicious use of current best evidence in making decisions 
about the care of communities and populations in the domain of health protection, disease 
prevention, health maintenance and improvement (health promotion)” (Jenicek, 1997). 
More recent definitions claimed evidence-based public health as a process of integrating 
science-based interventions with community preferences to improve the health of 
populations (Kohatsu et al., 2004), which is also very similar to the definition of evidence-
based medicine, but with a much broader focus on interventions in (sub-)populations 
instead of the best intervention for individual patients. The term “science-based” in this 
context includes the involvement of a range of disciplines aside from epidemiology, which 
provide the science base for public health. These are, among others, medicine, toxicology, 
molecular biology, anthropology, nutrition, psychology, sociology, economics, and 
political science, which go along with the development and implementation of adequate 
and target- and need-oriented public health interventions. Furthermore, a relatively 
deliberately broad definition includes both quantitative and qualitative approaches to 
gathering information that can affect public health practice (Kohatsu et al., 2004). 
This highlights the idea that there cannot be one gold standard for methodological 
approaches such as RCTs, as is the case in evidence-based medicine. The comparatively 
broad perspective of evidence-based public health is intended to include different 
perspectives and to use a method that is adequate for answering a certain research question, 
to facilitate (further) evidence that should be included in the decision-making processes. 
An evidence-based approach to public health could potentially have several direct and 
indirect effects (Lhachimi et al., 2016). For that reason, public health interventions and 
policies are much more complex than those in any other research discipline. Although 
evidence-based public health has borrowed the term “intervention” from clinical 
disciplines, a clearly defined and measurable single intervention is lacking in the public 
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health arena. Public health interventions for a given issue are characterized by multiple 
approaches or aspects that include different operations within a community (Brownson et 
al., 2009b). Whereas a causal chain in clinical interventions usually leads directly from an 
intervention to an outcome, in public health the intervention frequently focuses on a risk 
factor as the mediator between intervention and outcome (Attena, 2014). The context 
becomes more uncertain, variable, and complex when moving from clinical interventions 
to population-level and policy interventions (Dobrow et al., 2004). In addition, population-
based studies generally require a longer time period between intervention and outcome 
(Brownson et al., 2009b). To cover these different kinds of complexities, Eriksson (2000) 
proposed four domains in which sufficient information is needed to promote an evidence-
based approach in public health: 1) Distribution of health (e.g. indicators of social 
inequality), 2) determinants of health, 3) impact of disease or health problem on the 
individual as well as society, and 4) methods for changing health determinants.  
 
2.2 Environmental epidemiology  
Dahlgren and Whitehead (1991, 1993) defined different levels of (social) determinants of 
health. They described a social ecological theory to health. According to them, health is 
determined by a complex interaction between individual (lifestyle) factors, social and 
community networks, living and working conditions, and general socioeconomic, cultural, 
and environmental conditions. Therefore, the levels lead from very narrow aspects to much 
broader aspects. The most distant level from the perspective of an individual person is the 
broad concept of “environment”, which can furthermore be divided into a natural, built, or 
social environment (Dahlgren and Whitehead, 1991, 1993). Irrespective of this framework, 
in the understanding of environmental health, “environment” can also be defined as 
everything that is external to a human being (Last, 2001). Nevertheless, there are also other 
ideas on environment and perspectives on its interaction with health, such as distinctions 
between 1) inner and outer environment, 2) personal and ambient environment, 3) solid, 
liquid, and gaseous environments, and 4) physical, chemical, biological, and psychosocial 
environments (Merrill, 2008). 
Environmental health is a fairly broad concept, whereas environmental epidemiology 
focuses on populations and emphasizes identifying causal relationships between a risk 
factor and an outcome (Merrill, 2008). Environmental epidemiology is a distinct area of 
epidemiological studies. This is a result of the fact that populations exposed are large and 
diverse. Studying the effects, however, is quite complex, because an effect may be small or 
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not easy to define (Pekkanen and Pearce, 2001). Nevertheless, the importance of 
environmental epidemiology lies in the large number of people affected and the 
opportunity to protect a large part of different population groups through public health 
actions. Historically, findings from environmental epidemiology are well-known in the 
public health community, and led to significant improvements in the health of human 
populations. For example, one of the earliest and most influential epidemiological studies 
was performed by John Snow, when he used a quantitative approach to trace the cause for 
London’s cholera outbreak to sewage in drinking water (Overhage et al., 2013; Snow, 
1855).  
At least three features of environmental epidemiology distinguish it from general 
epidemiology. First, many environmental risk factors, or at least anthropogenic factors, are 
modifiable. Second, environmental factors are spatially distributed. Third, environmental 
exposures vary temporally. Therefore, within the course of a person’s lifetime, exposures 
come and go or vary in intensity. All of these aspects pose different challenges for creating 
evidence regarding the effects of a certain risk factor on different kinds of outcomes 
(Thomas, 2009). Risk assessment of environmental factors involves four stages: First, the 
hazard should be identified. Next, the exposure and dose-response relationship are 
assessed. The final step is risk characterization (Brunekreef, 2008). During this process, the 
Bradford Hill criteria for causality must be considered (Hill, 1965). 
Until now, many systematic assessments of epidemiological evidence were not able to 
draw causal hypotheses. This is a result of interstudy heterogeneity in design, methods, and 
reporting. Therefore, public health decision-making is severely limited because of the 
absence of concordance among study results (LaKind et al., 2015). This leads to a 
desideratum for evidence-based epidemiology (Overhage et al., 2013), which is 
particularly important in environmental epidemiologic research, for which the accurate 
characterization of an individual’s level of exposure is highly relevant but also highly 
challenging.  
Nevertheless, there have been several successful examples of results from environmental 
epidemiological studies leading to policy changes. For example, epidemiology played a 
central role in informing policy choice and evaluating the consequences in the area of 
tobacco control to protect smokers, as well as non-smokers who are exposed to SHS 





3. Second-hand smoke 
Tobacco is one of the largest contributors to indoor air pollution. SHS is responsible for 
many adverse health effects in non-smokers (Thompson, 2014). SHS exposure, also known 
as tobacco smoke pollution or exposure as a result of passive smoking, is expressed as the 
“sum of exposures in the multiple microenvironments where a person spends time” (Avila-
Tang et al., 2013). The smoke dilutes in the ambient air, diffuses, and spreads through it 
(Jousilahti et al., 2002; Klus, 1990). The indoor SHS concentration depends on the number 
of tobacco products smoked over a period of time, the volume of the room, the ventilation 
rate, and other processes that may eliminate pollutants (Apelberg et al., 2013; Leone et al., 
2004; Reardon, 2007; Svendsen et al., 1987). The exposure mainly consists of the smoke 
released from the burning end of a smoldering cigarette, pipe, or cigar (“side-stream 
smoke”, 85%) and, to a lesser extent, the smoke exhaled from the lungs of an active 
smoker nearby (“main-stream smoke”, 15%) (Ahijevych and Wewers, 2003; Dunbar et al., 
2013). Main-stream smoke travels through the unburnt tobacco and exits directly into the 
oral cavity and respiratory tract of the smoker (Spitzer et al., 1990). The composition of 
side-stream smoke differs substantially from main-stream smoke because of the different 
temperatures at which the substances burn and the oxygen supply (Svendsen et al., 1987). 
Side-stream smoke is considered more toxic than main-stream smoke because it contains a 
higher concentration of many dispersed pollutants over a longer exposure time (Pagani and 
Fitzpatrick, 2013; Remmer, 1987; Schick and Glantz, 2005; Witschi et al., 1997a; Witschi 
et al., 1997b). For example, side-stream smoke includes approximately five times as much 
carbon monoxide (which decreases the ability of hemoglobin to carry oxygen to the 
tissues), three times as much benzopyrene (which is a tumor- and plaque-producing 
compound), and 50 times as much ammonia (an eye and respiratory system irritant) as 
main-stream smoke (Ciruzzi et al., 1998; Leone et al., 2004; Raupach et al., 2006; Taylor 
et al., 1992). Furthermore, particulates are larger in main-stream smoke as in side-stream 
smoke. Therefore, side-stream smoke may reach more distant alveolar spaces in the lung 
(Leone et al., 2004; Stober, 1984).  
Inhaled tobacco smoke contains, for both active and passive smokers, more than 4,700 
different chemicals, such as nicotine—a pesticide (U.S. Department of Health and Human 
Services, 2006). More than 200 of these chemicals are confirmed carcinogens and 
respiratory toxins (Best, 2009; Dunbar et al., 2013; IARC, 2004; King et al., 2010; U.S. 
Department of Health and Human Services, 2006, 2014). For this reason, it is likely that 
SHS exposure causes some or all of the complications caused by active smoking. Chronic 
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exposure to SHS is suggested to be, on average, 80%–90% as harmful as chronic active 
smoking (Dinas et al., 2014). Scientific evidence has confirmed a dose-response 
relationship with no risk-free level of exposure (threshold dose) (Giovino, 2007; Jin et al., 
2013; Smith et al., 2000; WHO, 2008). For the association between SHS exposure and 
lung cancer, this dose-response relationship has been estimated to be linear. Here, the 
excess risk associated with SHS exposure is about 1% of that from smoking 20 cigarettes 
per day, which is consistent with the exposure (Hackshaw et al., 1997; Law and Wald, 
2003). In contrast, the dose-response relationship between SHS exposure and ischemic 
heart diseases (IHD) did not confirm a linear relationship. A meta-analysis including five 
large prospective epidemiological studies concerning the association between active 
smoking (around 20 cigarettes per day) and cardiovascular diseases calculated a relative 
risk (RR) of 1.78 (Law et al., 1997). Overall, active smoking exposes smokers to 
approximately 150–200 times the SHS concentration, and 100- to 300-fold total smoke 
dose experienced by a non-smoker (Smith and Ogden, 1998). Despite the much lower 
smoke exposure, several studies investigating the association between SHS exposure and 
cardiovascular diseases estimated an RR of around 1.3 (Barnoya and Glantz, 2005; He et 
al., 1999; Law et al., 1997; Rostron, 2013; Smith et al., 2000; Thun et al., 1999).  
A study by Repace and Lowrey (1985) estimated that the exposure to SHS for the non-
smoking adult population was about 1.43 mg of tar per day. Compared with this amount, a 
smoker is expected to inhale about 200–400 mg of tar per day (depending on the type of 
cigarette and frequency of smoking) (Howard and Thun, 1999; Svendsen et al., 1987). 
Other studies estimated that the level of exposure to SHS, measured by biochemical 
markers, is equivalent to 0.1–2 cigarettes per day (Feyerabend et al., 1982; Hein et al., 
1991; Hugod et al., 1978; Jarvis et al., 1984; Matsukura et al., 1984; Wald et al., 1984).  
 
3.1 Toxicology and pathophysiology 
There is a broad scientific consensus that SHS exposure is linked to carcinogenesis, in 
particular lung cancer (Hackshaw et al., 1997; Lee et al., 1986; Schick and Glantz, 2005; 
Vineis et al., 2005; Wald et al., 1986; Wells, 1998). This association is comprehensible, as 
more than 50 carcinogens have been identified in SHS (U.S. Department of Health and 
Human Services, 2006). Although the causal relationship is well-established in studies 
with animals, evidence for the underlying mechanisms in humans is still lacking. 
Nevertheless, data from active smokers may help to explain the framework of tumor 
induction in humans caused by SHS exposure. The most plausible mechanism is metabolic 
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activation following carcinogen uptake, which may lead to damage of the deoxyribonucleic 
acid (DNA). Tobacco-related carcinogens are associated with a decreased capacity of DNA 
to repair itself, which is associated with an increased risk of non-small-cell lung cancer 
(Shen et al., 2003). Multiple genetic changes may accumulate in (lung) cancer (U.S. 
Department of Health and Human Services, 2006). 
The scientific community first focused on the associations between SHS exposure and lung 
cancer. Subsequently, however, other outcomes were also included in the research, such as 
IHD (He et al., 1999; Law et al., 1997; Thun et al., 1999), respiratory diseases (Chen, 
2008; Coultas, 1998; Jindal and Gupta, 2004), and stroke (Bonita et al., 1999; McGhee et 
al., 2005; You et al., 1999). Several mechanisms may lead to an increased likelihood of 
adverse effects in the cardiovascular and respiratory system (Ahijevych and Wewers, 2003; 
Ambrose and Barua, 2004; Barnoya and Glantz, 2005, 2006; Rostron, 2013; Rubenstein et 
al., 2004; Sargent et al., 2004). These include increased platelet activation and subsequent 
thrombosis (Glantz and Parmley, 1991, 1995, 2001), inhibition of vascular endothelium 
and changes in endothelial functioning (Davis et al., 1989), impairment of coronary artery 
dilatation capacity (Celermajer et al., 1996; Otsuka et al., 2001; Schächinger et al., 2000; 
Sumida et al., 1998), decreases in antioxidant substances (Valkonen and Kuusi, 1998), 
aortic stiffening (Stefanadis et al., 1998), and impaired heart-rate variability (Pope et al., 
2001). These mechanisms may cause a reduction in vascular flow and therefore the 
development of atherosclerosis (Powell, 1998; U.S. Department of Health and Human 
Services, 2006). The mechanisms by which SHS exposure increases the risk of heart 
disease are multiple and interact with each other (Barnoya and Glantz, 2005).  
In comparison with lung cancer, there is one important difference in the association 
between SHS exposure and IHD. In lung cancer, adverse health effects result from long-
term exposure, whereas in IHD these effects are not merely long-term and chronic but also 
acute (Davis et al., 1989; Wells, 1994). Acute effects from SHS exposure are tissue 
irritation, especially of the eyes, but also of the nose, throat and respiratory tract 
(Muramatsu et al., 1983; Trédaniel et al., 1994; Weber, 1984; Willes et al., 1992). Acute 
effects on the cardiovascular system in terms of a decrease in platelet sensitivity that leads 
to greater platelet aggregation and increased risk of coronary thrombosis have been 
observed after an exposure of 20 minutes to 8 hours (Metsios et al., 2010; Otsuka et al., 
2001; Wells, 1994). Additionally, acute exposure to SHS reduces oxygen delivery and use 
in the myocardium (Gvozdjáková et al., 1992), causes mild coronary vasoconstriction, and 
damages the endothelium (Davis et al., 1989). The reductions in heart-rate variability occur 
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2 hours after exposure and increase the risk of myocardial infarction by around 10% (Pope 
et al., 2001; Sargent et al., 2004). Other acute effects include the deterioration of serum 
antioxidant defense, accelerated lipid peroxidation, and accumulation of low density 
lipoprotein (LDL). LDL cholesterol accumulation in macrophages is generally accepted as 
a key event of atherosclerosis (Brown and Goldstein, 1983; Pechacek and Babb, 2004; 
Valkonen and Kuusi, 1998). The effects of even brief passive smoking (minutes to hours) 
are often nearly as great as (chronic) active smoking (Barnoya and Glantz, 2005; Ding et 
al., 2009; Lippert and Gustat, 2012; Sargent et al., 2004).  
Until now, only a few studies have investigated possible mechanisms underlying sex 
differences in adverse health outcomes, such as IHD related to SHS exposure. It is 
assumed that the anti-estrogenic effect of cigarette smoking—and therefore also the 
exposure to SHS—may be at least partly related to the increased risk of IHD in young 
female smokers (Baron et al., 1990). Furthermore, a study by Geisler et al. (1999) 
indicated that in smoking women undergoing estrogen replacement therapy, plasma levels 
of estrogen were 40%–70% lower than in non-smoking women. Additionally, a decrease in 
both estradiol and testosterone concentrations in smoking men has been reported (Hsieh et 
al., 1998). Therefore, hormonal factors seem to considerably influence vulnerability to 
SHS exposure. This may also explain gender differences in the effects of SHS exposure 
(Bolego et al., 2002). 
 
3.2 Adverse health effects caused by SHS exposure 
SHS is increasingly being recognized as a major public health concern and risk factor in 
population health. Consistent adverse health effects caused by SHS exposure were reported 
in a Cochrane review (Callinan et al., 2010). SHS is the cause of several chronic diseases, 
including respiratory and cardiovascular conditions such as myocardial infarction, and 
may, for example, lead to a 25%–30% increase in the risk of coronary heart disease (Been 
et al., 2013; Dunbar et al., 2013). Studies have indicated that the acute effects of SHS are 
also harmful (Dacunto et al., 2014; Dinas et al., 2014). The health consequences that are 
causally linked to SHS exposure differ between ages and sexes (U.S. Department of Health 
and Human Services, 2014). Some risk groups suffer more from the adverse health effects 
caused by SHS exposure, particularly children (Tanski and Wilson, 2011) and pregnant 
women (Lee et al., 2011; Lee et al., 2012; Nichter et al., 2010; Stillerman et al., 2008). At 
least 40% of children and around 30%–35% of adult non-smokers are regularly exposed to 
SHS worldwide (Been et al., 2013; Öberg et al., 2011). The main exposure occurs at home, 
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which is a common location for exposure to SHS (Jin et al., 2013; Singh and Lal, 2011). 
Concerning health behavior, it has been observed that children of smokers are more likely 
to become smokers themselves (Longman and Passey, 2013).  
However, in addition to exposure during childhood, exposure during pregnancy is also an 
important factor in children’s health (Eiden et al., 2011). It has been estimated that a third 
to a half of non-smoking pregnant women are involuntarily exposed to SHS. Therefore, 
these women and their unborn children face an increased risk of a range of adverse health 
effects (Best, 2009; Mbah et al., 2013). Non-smokers, and particularly children living in 
households with at least one active smoker, are exposed to high levels of pollutants that 
negatively affect their health status (Kusel et al., 2013). Globally, the annual excess in 
deaths among children younger than five as a result of SHS exposure was estimated in 
1997 at close to 6,000, thereby exceeding deaths from all injuries combined (Aligne and 
Stoddard, 1997). For this reason, child exposure to tobacco smoke in domestic settings has 
become an international concern (Brooks et al., 2011; Pagani and Fitzpatrick, 2013; 
Hawkins and Berkman, 2014).  
 
3.3 Public health interventions to protect from SHS exposure 
The above-mentioned aspects highlight the relevance of considering SHS a risk factor for 
adverse health effects. Therefore, several public health interventions have been 
implemented to protect the population from adverse health effects caused by SHS 
exposure. In particular, the publication of the Surgeon General’s Report in 1986 (U.S. 
Department of Health and Human Services, 1986), in which SHS exposure was declared to 
be a cause of lung cancer in healthy non-smokers, led to an increase in the number of 
smoking bans and restrictions (Callinan et al., 2010). In 2003, the World Health 
Organization (WHO) ratified the Framework Convention on Tobacco Control (FCTC) 
(WHO, 2003). This is an evidence-based treaty that sets out a legislative framework for 
tobacco control, including recommendations for the development, implementation, and 
enforcement of national smoke-free legislation. Smoke-free legislation, consistent with the 
FCTC recommendations, has now been introduced in many countries (Mackay et al., 2010; 
Yach, 2014). The FCTC aims to offer price and tax measures, as well as non-price 
measures, to reduce the demand for tobacco (WHO, 2003).  
Bans and policies for tobacco control can be implemented through public health policies or 
legislation affecting populations at a national, state, or community level (Callinan et al., 
2010; Liang et al., 2016). A Cochrane review summarizing 25 studies observed consistent 
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positive health effects after the implementation of legislative smoking bans. All studies 
showed reductions in the duration of self-reported SHS exposure, ranging from 71% to 
100%, or in the percentage of those exposed, ranging from 22% to 85% (Callinan et al., 
2010). Other studies claim that smoke-free housing policies may be an effective strategy to 
reduce exposure to indoor SHS (Kingsbury and Reckinger, 2016). Nevertheless, a recent 
Cochrane review focused on the impact of institutional smoking bans. One of the main 
conclusions was that the evidence was not sufficient, because of low-quality primary 




Although a large number of studies have been published on the impact of SHS on health 
and on the effects of public health interventions to protect populations from SHS exposure, 
some evidence is still controversial, so that the need for adequate study designs remains 
(Künzli and Perez, 2009).  
For that reason, the papers included in this cumulative dissertation aim to shed light on 
how evidence in the research field dealing with SHS exposure is created and what has to be 
considered for further research. The publications focus on several aspects related to SHS 
exposure, be it 1) the impact of SHS exposure on health (P1), or 2) the effects of 
legislation to reduce SHS exposure (P2), 3) factors associated with SHS exposure in 
different countries (P3–5), including results from different settings (P3) or different types 
of SHS exposure (P4), or 4) a summary of challenges in creating evidence in 
environmental health risk assessments using SHS exposure as an example (P6).  
The synthesis, and the publications themselves, should lead to answering the following 
major research questions, which build on one another: 
 What are the major methodological challenges in environmental epidemiological 
studies on SHS exposure? 
 What are the implications of an evidence-based approach for public health 
research? 
 What conclusions can be drawn for future research to facilitate evidence-based 
decision-making in public health? 
To provide an answer, or at least a further contribution to the scientific discourse in this 
area, the following part will focus on selected portions of the publications belonging to this 
cumulative dissertation. Several challenges will be highlighted and discussed to provide 
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insight into different aspects that are essential for evidence-based public health derived 
from environmental epidemiological studies. This synopsis is not intended to repeat or 
discuss all individual results from the underlying publications. Rather, it aims to highlight 
those aspects that are important for generating evidence in public health by using 
environmental epidemiological studies. The public health action cycle (Ruckstuhl et al., 
1997) will be used as a framework for describing the results and setting them into the 




The publications rely on different methodological concepts. Overall, only secondary data 
were used, but differences in the methodological handling exist. The methods of the 
publications are only described briefly here. A detailed description can be found in the 
publications themselves (see Appendix). 
 
5.1 Impact of SHS exposure on health 
The first paper (P1) is based on a systematic literature review that was conducted in 
PubMed to identify articles dealing with the association between SHS and three health 
outcomes (IHD, chronic obstructive pulmonary disease [COPD], and stroke). This review 
was performed according to the procedure and requirements described in the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Moher 
et al., 2009). All studies identified by the search algorithm and published by 2014 were 
assessed. All full-text articles were subjected to a quality assessment. Sixteen criteria were 
used to assess the risk of 1) selection bias and 2) misclassification bias, as well as to judge 
3) the adequacy of data analysis. In considering selection bias, criteria differed for case-
control and cohort studies, which were the only study designs included in the systematic 










Table 1: Criteria for quality assessment of studies included in the systematic review of P1 
case-control study cohort study 
Selection bias 
Cases randomly selected or all cases in a specific 
population included 
Subjects randomly selected or all subjects in a 
population included 
Cases identified without knowledge of exposure 
status 
Subjects identified without knowledge of disease 
status 
Control drawn randomly from the same population 
of cases 
Comparison of persons who did and did not 
participate  
Response rate for identified cases and controls 
> 70%  
Response rate and follow-up rate > 70%  
Misclassification bias 
Exposure evaluations made in relation to the time of diagnosis   
Exposure validated by biomarker (and not [only] via self-report) 
Specific disease criteria provided  
Disease validated by histology or other gold standard  
Data analysis 
Adjustment or matching for potential confounders 
Power calculations performed 
Sample size sufficient  
Precise p-values and CIs given 
 
The systematic literature review formed the basis for a meta-analysis including 24 full-text 
articles. The main goals of the meta-analysis were: 1) To test whether the study results 
were homogeneous and, if so, 2) to obtain a combined estimator of the effect magnitude 
for the association between SHS exposure and the outcomes IHD, COPD, and stroke. 
Within the meta-analysis, effect sizes stratified for sex and for both sexes combined were 
calculated for the relationship between SHS and the three selected outcomes (P1).  
 
5.2 Effects of legislation to reduce SHS exposure 
The calculated effect sizes were employed in a health impact assessment aimed at 
estimating the impact of SHS exposure in the German population (P2). For the health 
impact assessment, a software tool called DYNAMO-HIA (DYNAmic MOdeling for 
Health Impact Assessment) was used (RIVM, 2010). DYNAMO-HIA is a generic software 
tool applying a Markov model. It was designed to assist in the quantification of the impact 
of risk factors on health. Furthermore, it enables the quantification of changes in risk 
factors owing to interventions for various diseases on overall population health (Boshuizen 
et al., 2012; Lhachimi et al., 2012). The data for the population living in Germany and for 
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the disease prevalence of the three outcomes IHD, COPD, and stroke were already 
included in the software (Lhachimi et al., 2012) and directly used for the simulation. 
Additionally, the RR values for the association between SHS exposure and the outcomes 
calculated in the meta-analyses were applied to quantify the health effect of SHS. The RR 
for each outcome stratified by sex was used for each single age year in the simulation. 
Furthermore, the prevalence of SHS exposure was included in the analysis based on data 
from the GEDA 2009 survey (Lampert and List, 2010).  
DYNAMO-HIA aims to use an almost real-life population for modeling purposes. 
Therefore, the analysis is stratified by sex and age in one-year age categories up to the age 
of 95. To compare the effects of policies designed to reduce SHS exposure on future 
population health, the reference scenario (no change in SHS exposure) is compared with 
two other scenarios. In these, the transition probabilities between the risk-factor state of no 
SHS exposure and SHS exposure are changed. In the first scenario, a success rate of 20% 
in the reduction of SHS exposure is assumed for all age groups. The second scenario 
assumes the total eradication of SHS exposure (100% success rate). The simulation began 
in 2014 and covered 36 years to 2050 (P2).  
 
5.3 Factors associated with SHS exposure  
Three other studies were conducted to assess the factors associated with SHS exposure. 
These studies are based on secondary data from Germany (P3), the United States (P4), and 
Bangladesh (P5). For Germany, the data from the public use file of the German Health 
Update 2012 were taken (n = 13,933). Only non-smoking adults were included in the 
analysis (P3). The analysis in P4 is based on data from the National Youth Tobacco Survey 
2014, which provides a nationally representative sample of middle- and high-school 
students in the United States (n = 20,007). Women of reproductive age (n = 17,749) were 
included in the analysis of P5, which uses Bangladesh Demographic and Health Survey 
2011 as the data source. Therefore, regional and intercultural differences in the factors 
associated with SHS can be described. Furthermore, the various study populations were 
considered in the analyses.  
Factors potentially associated with SHS exposure were selected based on previous 
literature reviews. Only factors significantly associated in the bivariate analysis were 
included in the multivariable analyses—either multinomial logistic regression (P3, P5) or 
binary logistic regression (P4) models. The outcome parameter was always SHS exposure. 
This was either divided by exposed vs. not exposed (P4) or distinguished between different 
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categories of exposure (P3, P5). A stratification by the SHS exposure setting, such as 
workplaces, bars/discotheques, restaurants, at home or at the house of a friend, was 
conducted in P3. Furthermore, P4 also focused on different types of SHS exposure, such as 
1) overall SHS exposure, 2) SHS exposure from cigarettes, or 3) SHS exposure from 
electronic cigarettes. 
 
5.4 Evidence in environmental health risk assessments 
The last publication (P6) is based on a narrative literature review. In this review, the 
similarities in the approaches of evidence-based medicine and evidence-based public 
health are described. A focus is set on factors that are important to consider in conducting 
an adequate study in environmental epidemiology. Therefore, the selection of study 
designs, the assessment of key sources of exposure, and aspects regarding stratification of 




The public health action cycle provides a systematic and comprehensible way to highlight 
the stages in public health decision-making and implement public health interventions. It 
may serve as an instrument for developing adequate strategies to reduce risk factors, foster 
healthy behaviors or settings, and, therefore, promote population health. Overall, different 
aspects of quality at the levels of structure, process, and outcomes (Donabedian, 1966, 
1988) must be ensured during the development, implementation, and evaluation of public 
health activities (Ruckstuhl et al., 1997). The idea of the public health action cycle goes 
back to the plan-do-check-act (PDCA) cycle, also known as the Deming cycle, which is an 
iterative four-step management method used in business for the control and continual 
improvement of processes and products (Deming, 1989). In addition, the Institute of 
Medicine had described the functions of governments in public health in a paper called 
“The Future of Public Health” (Institute of Medicine, 1988) in 1988, at a time when 
academization by implementation of national initiatives for research and training in public 
health was in the early stage of development in Germany (Nationale Akademie der 
Wissenschaften Leopoldina et al., 2015; von Troschke, 2001).   
The public health action cycle distinguishes between four categories or phases which may 
be used for strategic planning for all activities taking place in public health. Therefore, it is 
not restricted to only individual interventions, but rather allows a broader view of measures 
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to improve populations’ health. These phases within a circular process are 1) assessment, 
2) policy formulation, 3) implementation, and 4) evaluation (see Figure 1).  
 
 
Figure 1: The public health action cycle (Institute of Medicine, 1988; Ruckstuhl et al., 1997) 
 
Keeping in mind the need for evidence-based public health, the four stages will now be 
used as a framework to briefly name the most important aspects to consider in 
environmental epidemiological studies using the example of SHS exposure. It should be 
noted that not all aspects can be strictly divided between the stages. The argument for the 
requirements regarding evidence is overarching and, therefore, sometimes overlaps the 
stages. Evidence is the fundamental basis for the first two stages (assessment and policy 
formulation), but also highly important for the implementation stage. The evaluation stage 
is required to create more evidence.  
 
6.1 Assessment 
All actions in public health should be based on current research evidence, because 
knowledge about cause and effect is a decisive element in public health practice. As 
mentioned by the Institute of Medicine (1988), it is essential to “regularly and 
systematically collect, assemble, analyze, and make available information on the health of 
the community, including statistics on health status, community health needs, and 
epidemiologic and other studies of health problems” (Institute of Medicine, 1988, p. 7). 
This study adds information on the effect sizes for the association between SHS exposure 
and three outcomes (IHD, COPD, and stroke). This is the first study to calculate effect 
sizes for the association between SHS exposure and the disease outcomes IHD, COPD, and 







exposure, because positive, and mostly significant, results were found for the association 
between SHS exposure and the three outcomes for both sexes. 
A major added value in terms of evidence is the fact that the same methods were used for 
calculating the effect sizes. Otherwise, it would be somehow difficult to compare results 
from other primary studies or systematic reviews. This is another finding from P1, that 
there is quite a large heterogeneity in the quality and reported effects between studies. This 
is mainly attributable to the fact that study designs differ greatly. In particular, the 
measurement of exposure is crucial in the field of SHS exposure. Many studies rely on 
self-reports, and the definitions or ways to request SHS exposure information differ (P6). 
In addition, many studies assess both the exposure and the outcome by self-reports (P3–
P5), which may lead to biased results. These biases make a health impact assessment (P2) 
difficult, because a lack of knowledge about actual exposure (P3–P5) or dose-response 
relationship (P6) will lead to inadequate or highly uncertain results. Nevertheless, these 
kinds of data are necessary to provide adequate information on population health and the 
factors associated either with adverse health effects or—as in the case of SHS exposure—
the risk factors impacting health. 
 
6.2 Policy formulation 
Furthermore, it must be considered that the factors associated with SHS exposure may 
differ on a small-scale level between individual characteristics of the people within a 
population (such as age, sex, or socioeconomic status) or on a large-scale level between 
various countries or regions (P3–P6). These differences should be taken into account when 
developing target-specific interventions. Therefore, studies that focus on subgroups and 
their particular SHS exposure, as well as their needs, are necessary.   
P3, based on data from Germany, notes that the factors associated with SHS exposure vary 
between locations of SHS exposure. For example, males were more likely to be exposed to 
SHS in the workplace and in bars or discotheques than women. In comparison, women 
were more likely than men to be exposed to SHS at home or at the house of a friend. This 
indicates the relevance of target-specific interventions that take into account the setting of 
SHS exposure and other characteristics of the risk groups. Within the publications included 
in this analysis, two particularly vulnerable subgroups for SHS exposure and related 
adverse health effects have been included. These are women (P5) and children (P4). In 
addition, P4 found that the factors associated with SHS exposure may differ if the results 
are stratified by the type of exposure (overall, cigarette, or electronic cigarette exposure). 
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Therefore, the characteristics of exposure and exposed subpopulations should be 
considered during the development of adequate public health policies and interventions.  
 
6.3 Implementation 
This study did not focus on any specific type of public health intervention implemented to 
reduce SHS exposure. Nevertheless, an evidence-based strategy is not only necessary in 
the preceding stages, where the problem is defined and the intervention is planned; the 
implementation also plays a major role. It can be referred to another publication by the 
author of this dissertation, which focuses on aspects of guideline implementation (Fischer 
et al., 2016). Successful interventions should also focus on what was done well in other 




The last but not least important step of the public health action cycle is the evaluation. This 
evaluation should focus primarily on the effectiveness but also on the efficiency of the 
chosen intervention, to create more evidence. In P2, a health impact assessment was 
performed which was actually not the evaluation of an intervention, but rather an 
estimation of the effects of legislation to reduce SHS exposure on population health. 
Again, such estimates may be prone to bias, because interventions in public health are 
complex processes involving several interacting components, with a lack of linear, well-
evidenced causal pathways linking the intervention and health outcomes. This should be 
taken into account when designing and interpreting studies in the field of environmental 
epidemiology or evaluations of public health interventions.  
After the evaluation, the process of the public health action cycle can start again. That 
means evidence-based public health is a process with ongoing iterations, necessary for 
identifying the most effective and efficient measures to reduce health risks such as SHS 
exposure and their adverse health outcomes. A reiteration of this process is required 
because of social transformations and other developments, along with innovations in 
research and policy which lead to changes in attitudes and behaviors among the population. 
To evaluate certain interventions, methodological shortcomings in previous studies (such 
as potential misclassification, bias, or confounding) must be respected to allow the creation 





Activities in public health are characterized by complexity and indeterminacy, which pose 
a strong limitation, or at least a challenge, to evidence-based public health (Attena, 2014). 
This is also shown by the results presented within the publications included in this 
dissertation. This synopsis aimed to highlight the most important methodological 
considerations relevant for assessing the impact of SHS exposure on human health. 
Furthermore, where environmental epidemiological studies correspond with evidence-
based approaches and where the pitfalls are should be noted. 
Using the public health action cycle to describe results already indicates that evidence 
plays a crucial role in many, if not all, aspects of public health. Although there are 
similarities between evidence-based public health and evidence-based medicine, there are 
also some relevant differences. For example, the gold standard for inferences about causal 
relationships is an experimental study. This would typically be a double-blind RCT in 
clinical research. In public health, particularly in environmental epidemiology, this concept 
cannot be applied to all types of research. This aspect was referred to in an article 
published in the Christmas issue 2003 of the British Medical Journal. This humorous 
article presented the results of a systematic review of the effects of using a parachute 
during free-fall. The conclusion was that no RCTs that covered this research question 
existed (Smith and Pell, 2003). It does not have to be pointed out that the idea of an RCT is 
unethical and not feasible, but this illustrates once more the fact that an RCT as a gold 
standard is not applicable in all cases (Black, 1996; Hatt et al., 2015; Shelton, 2014).  
Environmental epidemiological researchers mainly rely on observational studies (Thomas, 
2009). This is linked to a risk for different types of biases and increasing uncertainties. 
Therefore, there are three basic requirements for addressing these uncertainties: 
1) Identification and evaluation of the sources of uncertainties, 2) evaluation of their 
combined effect on the outcome of the assessment, and 3) communication of these 
uncertainties to policymakers and the public (Brownson et al., 2009b; LaKind et al., 2015).   
For applying an evidence-based approach in public health using epidemiological studies as 
the fundamental basis, major attention should be paid to the assessment of exposure and 
risk. Therefore, the Bradford Hill postulates for causality are of major relevance, because 
they include the strength of association, consistency, specificity, temporality, biologic 
gradient, plausibility, coherence, data based on experiments, and analogy (Hill, 1965). As 
mentioned, not all of these criteria can be applied in the field of public health, but it is 
worth considering these factors.  
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One of the most challenging tasks in environmental epidemiology deals with the estimation 
of health effects associated with past patterns of exposure and the prediction of effects that 
may occur in the future as a result of continued or projected exposure. Therefore, exposure 
assessment is an essential aspect of a study’s quality. A more accurate assessment of 
exposure can increase the power of an environmental epidemiological study by reducing 
misclassification of confounders and modifiers. The results of the meta-analysis (P1) and 
also of the other studies using secondary data (P3–P5) highlight the need for focusing on 
adequate methods to assess and report the exposure thoroughly, because several major 
differences exist regarding the definition and measurement of SHS exposure. For example, 
studies included in the meta-analysis (P1) used various definitions of SHS exposure, 
focusing either on certain settings, such as the home or workplace, or relied only on 
information such as “spousal smoking”, without any further assessment of the frequency, 
duration, or intensity of exposure (Avila-Tang et al., 2013; Bentayeb et al., 2013). For this 
reason, information on SHS exposure may be inexact or poorly reported (Barnoya and 
Glantz, 2005; He et al., 1999). Using spousal smoking, for example, as the sole marker of 
SHS exposure, may lead to a downward bias resulting from exposure misclassification 
(Ahijevych and Wewers, 2003; Pron et al., 1988).  
Since many studies focused on SHS exposure at home irrespective exposure that may take 
place outside home, groups of people described as “unexposed” may include a not 
negligible proportion of persons with SHS exposure in other settings, such as the 
workplace (Hill et al., 2007). A review of nine epidemiological studies published before 
1992 noted that the lack of data on SHS exposure outside the home was one of the major 
weaknesses in the epidemiological evidence (Steenland, 1992). Therefore, studies may 
underestimate the risk from SHS exposure, because exposures at home may be smaller 
than exposures at the workplace (Glantz and Parmley, 1991). Although this argument may 
have changed following the implementation of smoke-free laws, which led to the greatest 
source of SHS exposure being the home (Enstrom and Kabat, 2006), it still highlights the 
importance of including different settings in calculating SHS exposure, which P3 did. 
Furthermore, the differences in the type of SHS exposure studied in P4 are relevant. This is 
confirmed by a study focusing on different cigarette sizes and brands, which indicated 
significant type-specific differences for emitted particulate matter concentrations (Kant et 
al., 2016). Overall, difficulties in ascertaining SHS exposure may explain the lack of 
precision in several estimates (Bonita et al., 1999). 
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Epidemiological studies must measure the intensity and duration of SHS exposure by using 
adequate study designs—preferably cohort studies—to support causal associations. This is 
also needed to identify dose-response relationships. Until now, the meta-analysis could 
only compare exposed vs. not exposed people to calculate effect sizes (P1), and the studies 
focusing on the factors associated with SHS exposure (P3, P5) relied on very crude 
information regarding exposure. Furthermore, a disease may require a minimal level of 
exposure and increase in probability with a longer exposure period. A further limitation is 
that many studies reasonably desire to focus on the isolated association between a given 
exposure and an adverse health effect. Nevertheless, assessing combined effects of 
multiple exposures is important in the field of public health, because interventions often 
target an overall exposure scenario (Hertz-Picciotto, 2008; Merrill, 2008).   
Information on past exposures may either not be available or of poor quality because self-
report assessments are prone to recall bias or other types of information bias (Thomas, 
2009). For that reason, it is expected that biological markers of exposure may improve 
current estimates of exposure in environmental epidemiologic research. A more accurate 
assessment of SHS exposure may improve the sensitivity of epidemiologic studies to detect 
associations (especially weak associations) between exposures and adverse health 
outcomes. Furthermore, misclassification of exposure measures can be reduced. In general, 
non-differential misclassification causes measures of effect to be biased toward the null 
value, whereas differential misclassification can result in bias either toward or away from 
the null value (Rothmann et al., 2008).  
Although some earlier studies found that the reliability of self-classification of SHS 
exposure is moderate to very good (Brownson et al., 1993; Coultas et al., 1989; Eisner et 
al., 2005; Emmons et al., 1994; Hammond and Leaderer, 1987; Pron et al., 1988), 
nowadays the evidence indicates that self-reported information is an imprecise measure to 
assess SHS exposure (Jefferis et al., 2010; Lightwood et al., 2009). The sensitivity of SHS 
exposure assessment by self-reports may vary between the domestic setting and work-
related settings or public places (Iribarren et al., 2004). Furthermore, subjective reports of 
SHS exposure are subject to recall and reporting biases (Bentayeb et al., 2013).  
In the case of SHS exposure, there are some objective markers that can be used, although 
they vary regarding their suitability to detect dose-response relationships. Despite a 
missing gold standard for measuring SHS exposure (Kaur et al., 2004), one of the most 
frequently used biomarkers to assess SHS exposure is cotinine. Cotinine, which is a 
metabolite of nicotine, is commonly used as a biomarker for measuring SHS exposure 
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(Avila-Tang et al., 2013; Jefferis et al., 2010; Misailidi et al., 2014). It can be measured in 
blood, urine, and saliva (Bernert et al., 2000; Jarvis et al., 1984), and has a half-life of 
approximately 15–20 hours (Benowitz et al., 1983), which is much longer than the half-life 
of nicotine (2 hours) (Hawamdeh et al., 2003; Jarvis et al., 1988; Jarvis et al., 1987; 
Nondahl et al., 2005). Therefore, cotinine reflects SHS exposure during the previous 1–2 
days (Eisner et al., 2005; Hammond and Leaderer, 1987; Nondahl et al., 2005). An 
advantage of cotinine assessment is its ability to detect low quantities of serum cotinine, 
allowing the identification of low levels of SHS exposure among non-smokers (Nondahl et 
al., 2005). 
These challenges, among others, are discussed in P6. Evidence-based public health needs 
to take into account several aspects related to study design in environmental epidemiology. 
Overall, the aim of all these studies should be freedom from biases (Thomas, 2009) and 
confounding in study results. Within the quality assessment of the primary studies in the 
meta-analysis published in P1, controlling for possible effects of confounding was used as 
one criterion for the quality scale. Studies have used various determinants as potential 
confounders, such as age, gender, smoking status (if not only non-smokers were included), 
health status, and disease history. A recommendation for future epidemiological studies is 
to consider possible effects of confounding. This can be done by adjustment, matching, or 
more restrictive exclusion criteria for study participants (Chen et al., 2004; Dunbar et al., 
2013; McElduff et al., 1998). Confounding may be related both to the assessment of 
exposure and the outcome of interest (Iribarren et al., 2001). For example, smoking at 
some point during life may confound the effect of SHS exposure (Johannessen et al., 
2012). The potential for misclassifying the smoking status of former or even current 
smokers as passive smokers is a longstanding concern in studies using self-reports for 
assessing SHS exposure (Coultas, 1998). Therefore, the association between SHS exposure 
and adverse health effects should only be evaluated among never-smokers (Enstrom and 
Kabat, 2003), which most of the primary studies included in P1 already did.  
Whereas in evidence-based medicine, RCTs as the gold standard are particularly 
important, evidence-based public health should also focus on study design, but here it is 
crucial to select the right option and assess exposure and outcomes, as well as confounding 
factors, as accurately as possible. 
For the evidence-based public health approach, however, it is not enough to create 
evidence by methodologically sound scientific studies. The translation of the evidence into 
practice is at least equally important (Mitton et al., 2007). This matter of course is also 
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depicted in a definition of evidence-based health care, which “is characterized by decision-
making in which the decision is based on a systematic appraisal of the best evidence 
available” (Gray, 1997, p. 65). Alberg et al. (2014) called the last step of their framework 
for evidence-based public health “action”, and described it as the process in which steps 
are taken to protect society from harmful exposures, if a causal hypothesis was confirmed 
and public health action is warranted. Therefore, (environmental) epidemiological studies 
provide a foundation for decisions based on evidence. A large variation in the use of 
evidence-based decision-making practices has been shown (Bambra, 2013; Brownson et 
al., 2009a; Lovelace et al., 2015). For that reason, the gap between research and policy and 
practice must be bridged (Rychetnik et al., 2012), to accelerate the integration of scientific 
discoveries into routine public health practice (Fielding and Briss, 2006).  
 
 
8. Conclusion  
The entire dissertation project highlighted several intersections between evidence-based 
approaches and environmental epidemiology. The aim of this synopsis was not to add 
evidence to the already-growing body of literature regarding the association between SHS 
exposure and adverse health outcomes. Rather, it aimed to reflect on some methodological 
issues that should be considered in studies in the field of environmental epidemiology (as a 
subdiscipline of public health) in general and in effects of SHS exposure in particular. This 
should open the floor for further discussion in the scientific community. This exchange is 
important, because evidence-based public health is still considered underdeveloped 
(Brownson et al., 2009b; Latham et al., 2013).  
Environmental epidemiology and other scientific disciplines have much to contribute to 
facilitate population health (Aldrich et al., 2015). Although there may be several 
shortcomings in environmental epidemiological studies dealing with SHS exposure, this 
type of observational research is necessary. Evidence can also be derived from multiple—
well-conducted—studies to assess the impact of public health interventions, when the 
conduct of RCTs is difficult or impossible (Black, 1996; Heller and Page, 2002; LaKind et 
al., 2015). Therefore, the methodological constraints must be resolved. Although 
standardized approaches in public health are needed, particularly for the assessment of 
exposure and outcome in (environmental) epidemiological studies, a focus on only one 
gold standard is not justified. Since public health acts on several levels, an interdisciplinary 
approach that uses the most appropriate methods from the respective disciplines of 
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research traditions to create evidence is necessary. All decisions in public health should be 
evidence-based, irrespective of the area of interest. Therefore, public health researchers 
must succeed in using the most appropriate methods. Perhaps an approach termed 
“evidence-based environmental epidemiology” will be formulated in the future. However, 
all types of research conducted in public health must use sound methods. That, besides the 
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